BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1006 related articles for article (PubMed ID: 28901167)

  • 1. Effect of Ischemic Postconditioning on Myocardial Function and Infarct Size Following Reperfusion Injury in Diabetic Rats Pretreated With Vildagliptin.
    Bayrami G; Karimi P; Agha-Hosseini F; Feyzizadeh S; Badalzadeh R
    J Cardiovasc Pharmacol Ther; 2018 Mar; 23(2):174-183. PubMed ID: 28901167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretreatment with vildagliptin boosts ischemic-postconditioning effects on cardioprotection and expression profile of genes regulating autophagy and mitochondrial fission/fusion in diabetic heart with reperfusion injury.
    Pirzeh L; Babapour V; Badalzadeh R; Panahi N
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Nov; 392(11):1371-1382. PubMed ID: 31230090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The additive effects of ischemic postconditioning and cyclosporine-A on nitric oxide activity and functions of diabetic myocardium injured by ischemia/reperfusion.
    Badalzadeh R; Mohammadi M; Najafi M; Ahmadiasl N; Farajnia S; Ebrahimi H
    J Cardiovasc Pharmacol Ther; 2012 Jun; 17(2):181-9. PubMed ID: 21828282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic type-I diabetes could not impede the anti-inflammatory and anti-apoptotic effects of combined postconditioning with ischemia and cyclosporine A in myocardial reperfusion injury.
    Badalzadeh R; Azimi A; Alihemmati A; Yousefi B
    J Physiol Biochem; 2017 Feb; 73(1):111-120. PubMed ID: 27771871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Berberine Pretreatment Confers Cardioprotection Against Ischemia-Reperfusion Injury in a Rat Model of Type 2 Diabetes.
    Chang W; Li K; Guan F; Yao F; Yu Y; Zhang M; Hatch GM; Chen L
    J Cardiovasc Pharmacol Ther; 2016 Sep; 21(5):486-94. PubMed ID: 26846272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of Vildagliptin and Ischemic Postconditioning in Diabetic Hearts as a Working Strategy to Reduce Myocardial Reperfusion Injury by Restoring Mitochondrial Function and Autophagic Activity.
    Bayrami G; Alihemmati A; Karimi P; Javadi A; Keyhanmanesh R; Mohammadi M; Zadi-Heydarabad M; Badalzadeh R
    Adv Pharm Bull; 2018 Jun; 8(2):319-329. PubMed ID: 30023334
    [No Abstract]   [Full Text] [Related]  

  • 7. Characteristics of Dexmedetomidine Postconditioning in the Field of Myocardial Ischemia-Reperfusion Injury.
    Bunte S; Behmenburg F; Majewski N; Stroethoff M; Raupach A; Mathes A; Heinen A; Hollmann MW; Huhn R
    Anesth Analg; 2020 Jan; 130(1):90-98. PubMed ID: 31633505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility to myocardial ischemia reperfusion injury at early stage of type 1 diabetes in rats.
    Li H; Liu Z; Wang J; Wong GT; Cheung CW; Zhang L; Chen C; Xia Z; Irwin MG
    Cardiovasc Diabetol; 2013 Sep; 12():133. PubMed ID: 24041262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined remote perconditioning and postconditioning failed to attenuate infarct size and contractile dysfunction in a rat model of coronary artery occlusion.
    Sachdeva J; Dai W; Gerczuk PZ; Kloner RA
    J Cardiovasc Pharmacol Ther; 2014 Nov; 19(6):567-73. PubMed ID: 24607766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardioprotection by ischemic postconditioning is lost in isolated perfused heart from diabetic rats: Involvement of transient receptor potential vanilloid 1, calcitonin gene-related peptide and substance P.
    Ren JY; Song JX; Lu MY; Chen H
    Regul Pept; 2011 Aug; 169(1-3):49-57. PubMed ID: 21554904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic Co-Administration of Sepiapterin and L-Citrulline Ameliorates Diabetic Cardiomyopathy and Myocardial Ischemia/Reperfusion Injury in Obese Type 2 Diabetic Mice.
    Baumgardt SL; Paterson M; Leucker TM; Fang J; Zhang DX; Bosnjak ZJ; Warltier DC; Kersten JR; Ge ZD
    Circ Heart Fail; 2016 Jan; 9(1):e002424. PubMed ID: 26763290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial reperfusion injury management: erythropoietin compared with postconditioning.
    Tamareille S; Ghaboura N; Treguer F; Khachman D; Croué A; Henrion D; Furber A; Prunier F
    Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H2035-43. PubMed ID: 19617412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-lipoic acid preconditioning plus ischemic postconditioning provides additional protection against myocardial reperfusion injury of diabetic rats: modulation of autophagy and mitochondrial function.
    Mokhtari B; Abdoli-Shadbad M; Alihemmati A; Javadi A; Badalzadeh R
    Mol Biol Rep; 2022 Mar; 49(3):1773-1782. PubMed ID: 35098396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ischemic postconditioning protects remodeled myocardium via the PI3K-PKB/Akt reperfusion injury salvage kinase pathway.
    Zhu M; Feng J; Lucchinetti E; Fischer G; Xu L; Pedrazzini T; Schaub MC; Zaugg M
    Cardiovasc Res; 2006 Oct; 72(1):152-62. PubMed ID: 16901477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of mitochondrial permeability transition pore restores the cardioprotection by postconditioning in diabetic hearts.
    Najafi M; Farajnia S; Mohammadi M; Badalzadeh R; Ahmadi Asl N; Baradaran B; Amani M
    J Diabetes Metab Disord; 2014; 13(1):106. PubMed ID: 25436201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. rAAV9-Mediated MEK1 Gene Expression Restores Post-conditioning Protection Against Ischemia Injury in Hypertrophic Myocardium.
    Chen Y; Liu F; Chen BD; Li XM; Huang Y; Yu ZX; Gao XL; He CH; Yang YN; Ma YT; Gao XM
    Cardiovasc Drugs Ther; 2020 Feb; 34(1):3-14. PubMed ID: 32103377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-arrhythmogenic and anti-inflammatory effects of troxerutin in ischemia/reperfusion injury of diabetic myocardium.
    Najafi M; Noroozi E; Javadi A; Badalzadeh R
    Biomed Pharmacother; 2018 Jun; 102():385-391. PubMed ID: 29573617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes mellitus abrogates erythropoietin-induced cardioprotection against ischemic-reperfusion injury by alteration of the RISK/GSK-3β signaling.
    Ghaboura N; Tamareille S; Ducluzeau PH; Grimaud L; Loufrani L; Croué A; Tourmen Y; Henrion D; Furber A; Prunier F
    Basic Res Cardiol; 2011 Jan; 106(1):147-62. PubMed ID: 20981553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cardioprotective effect of dexmedetomidine on regional ischemia/reperfusion injury in type 2 diabetic rat hearts.
    Deng L; Chen H; Wei N; Zhang Z; Wang G
    Microvasc Res; 2019 May; 123():1-6. PubMed ID: 30179598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ischemic postconditioning protects the heart against ischemia-reperfusion injury via neuronal nitric oxide synthase in the sarcoplasmic reticulum and mitochondria.
    Hu L; Wang J; Zhu H; Wu X; Zhou L; Song Y; Zhu S; Hao M; Liu C; Fan Y; Wang Y; Li Q
    Cell Death Dis; 2016 May; 7(5):e2222. PubMed ID: 27171264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.